0.53CNY
580.07 MCNY
3.32 BCNY
408.89 M
About SHENZHEN SALUBRIS
Sector
CEO
Jie Yan
Headquarters
Shenzhen
Website
Employees (FY)
3.52 K
Founded
1998
ISIN
CNE100000FW8
FIGI
BBG000NNBT70
Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. Its products include cardiovascular drugs and medical devices; cephalosporin antibiotics and raw materials; and bone resorption inhibitor drugs. The company was founded on November 3, 1998 and is headquartered in Shenzhen, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 002294 is 28.91 CNY — it has increased by 0.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange SHENZHEN SALUBRIS stocks are traded under the ticker 002294.
SHENZHEN SALUBRIS is going to release the next earnings report on Apr 23, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for SHENZHEN SALUBRIS has a max estimate of 41.00 CNY and a min estimate of 41.00 CNY.
002294 earnings for the last quarter are 0.13 CNY whereas the estimation was 0.14 CNY which accounts for −7.14% surprise. Estimated earnings for the next quarter are 0.11 CNY. See more details about SHENZHEN SALUBRIS earnings.
SHENZHEN SALUBRIS revenue for the last quarter amounts to 610.00 M CNY despite the estimated figure of 1.43 B CNY. In the next quarter revenue is expected to reach 1.48 B CNY.
Yes, you can track SHENZHEN SALUBRIS financials in yearly and quarterly reports right on TradingView.
Like other stocks, 002294 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHENZHEN SALUBRIS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 3.52 K employees. See our rating of the largest employees — is SHENZHEN SALUBRIS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHENZHEN SALUBRIS EBITDA is 916.94 M CNY, and current EBITDA margin is 27.92%. See more stats in SHENZHEN SALUBRIS financial statements.